On September 7, 2023, BCY Pharm Co., Ltd. closed the transaction. The company's registered capital is CNY 36,616,250.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.48 CNY | -2.88% |
|
-2.27% | -23.58% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.58% | 727M | |
+55.95% | 819B | |
+43.62% | 638B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+16.30% | 242B | |
+2.41% | 225B | |
+12.47% | 217B | |
+8.91% | 168B |
- Stock Market
- Equities
- 301263 Stock
- News Guangdong Taienkang Pharmaceutical Co., Ltd.
- BCY Pharm Co., Ltd. announced that it has received CNY 150 million in funding from Guangdong Taienkang Pharmaceutical Co., Ltd